On Tuesday, April 2, 2019, letters from the Food and Drug Administration (FDA) and the Federal Trade Commission (FCC) were sent to three companies that market cannabidiol (CBD) products warning them against making false claims that their products can treat diseases like cancer and Alzheimer’s.
The three companies are: Nutra Pure, PotNetwork Holdings and Advanced Spine and Pain. Both agencies are saying that these companies’ advertising are making false claims about the effectiveness of their products which contain cannabidiol, which is commonly referred to as CBD.
The names that these product supplements are being marketed under are: “Hemp Oil,” “Liquid Gold Gummies,” “CBD Softgels,” “CBD for Dogs,” and “CBD Oil.” Nutra Pure in particular claims in their advertisements that scientific research concurs the effectiveness of their CBD product as an anti-seizure medication.
Some of the other claims that are being made in advertisements by these companies is that their products can treat diseases like cancer, fibromyalgia, Alzheimer’s disease, and ‘neuropsychiatric disorders, which both government agencies say is false in their joint warning letter.
According to the letters sent out to the three companies they have 15 days from receipt of the letter to notify the FTC if they have taken the necessary actions addressed by the agencies’ concerns.
Although this is the first time that the FDA and the FCC have jointly issued a warning letter, it isn’t the first time they have tried to put a stop to unfounded claims regarding CBD. Back in 2017, four companies were warned by the FDA to stop making false claims that their products which contained cannabis-based hemp and marijuana in them could treat cancer which had no proven statistics for them. Also in 2018, the FDA banned the use of CBD in food products.
What really is CBD (cannabidiol)? It comes from the hemp plant which is in the the cannabis family. So is marijuana, but they are two different plants yet closely related. They both contain a lot of cannabinoids but the difference between the two is that marijuana’s cannabinoids are high in a psychoactive chemical called THC but hemp’s is rich in CBD which is non-psychoactive.
In spite of the fact that their is little evidence that CBD does anything in the human body, it is sold as a medicinal source in a lot of products such as lattes infused with CBD, massage lotions and even baked goods for example.
There has been only one use for CBD so far that has been approved by the FDA and that is for treatment for two rare forms of epilepsy.